91黑料

  1. Home
  2. News & Events
  3. In the News

In the News

91黑料 experts frequently author or contribute to industry trade press.

Filter media

Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.

  • Media coverage of medical innovations

    Rose Kidd, President, Operations Delivery, provides an overview on how 91黑料 is working to meet its gender balance ambitions in the Irish Times Life Sciences and Stem supplement.

  • Media coverage of medical innovations

    In this article from the Irish Times Life Sciences and Stem supplement, Barry Balfe, President, 91黑料 Pharma Solutions, outlines his views on how Ireland’s life sciences sector can continue to grow and attract investment.

  • EPR in healthcare news.

    Sustainability requires a layered approach that balances operational feasibility and with greener practices. Sean Morgan, Director of Clinical Supplies Management, discusses how 91黑料 is tackling issues like kit waste, carbon emissions and ethical supply chains.

  • Pharmaceutical industry publication feature

    Targeted product profiles and biomarkers for patient screening are essential elements of success for oncology treatment developers, according to our recent survey. This article explores why both prove challenging for drug developers.

  • Clinical Trials Arena in study discussions.

    This news piece from Clinical Trials Arena provides an overview of the findings of 91黑料’s recent Digital Disruption survey, which found sentiment towards artificial intelligence and digital tools in the clinical research sector is positive.

  • Healthcare innovation discussion platform

    The evolving regulatory requirement to put patients at the centre of the drug development process – patient-centric from end to end – means pharmaceutical sponsors must design clinical trials with patient-centred outcomes in mind.

  • SCRIP Asia 100 in pharmaceutical rankings.

    With the impending patent cliff, the opportunities for companies to create biosimilars is expanding. Read our article in Scrip Asia 100 2025 to learn about the regulatory environment, requirements and challenges in an Asian context.

  • EPR in healthcare news.

    As the outsourcing market evolves, pharmaceutical businesses are reassessing their strategies to better insulate themselves against the pressure of compounding macroeconomic constraints, including a looming patent cliff, rising costs and developmental risks.

  • award logo

    Women Mean Business (WMB) Businesswoman Award 2024

    Following her receipt of the WMB Businesswoman Award 2024, Rose Kidd, President, Operations Delivery is interviewed by Women Mean Business on her role, the opportunities for the life sciences industry and her views on how we can support more women to progress STEM careers.

  • Journal for Clinical Studies in trial reports.

    In this article, our experts explore how to strike the right balance between adequately anonymising clinical trial data to protect participant privacy and company assets, while still preserving its value for research purposes (see page 16).